Rupatadine-(FDC- List) -(Nov 2009)
Drug Name:
Rupatadine-(FDC- List) -(Nov 2009)
List Of Brands:
Indication Type Description:
Drug Interaction:
Grape fruit juice Ketoconazole Eryhthromycin Other CYP3A4 A inhibitors Statins
Indication:
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Rupatadine 10mg 10-11-2009
+ Montelukast 10mg tablets
For the management of seasonal allergic rhinitis (SAR)
Allergic rhinitis Chronic idiopathic urticaria
Adverse Reaction:
Somnolence Headache, Dizziness, Fatigue Dry mouth
Contra-Indications:
Renal or hepatic impairment Special precautions- QT prolongation Hypokalemia Pro-arrhthmic conditions including bradycardia Acute myocardial ischemia Elderly Pregnancy Lactation
Dosages/ Overdosage Etc:
Allergic rhinitis Chronic idiopathic urticaria
Dosage-
1 tab daily
Pregnancy and lactation:
Use contraindicated Observe caution